Ignacio Blanco

Ignacio Blanco

Auto-generated profile, based on publicly available information

Ignacio Blanco

Alpha1-Antitrypsin Deficiency Spanish Registry (REDAAT), Spanish Society of Pneumology and Thoracic Surgery (SEPAR), Barcelona, Spain

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2014 in Journal of Internal Medicine
Verified
Journal Article
Closed access
PDF file
FSF. de Serres
F. de Serres
IBI. Blanco
I. Blanco

1 January 2006 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
IBI. Blanco
I. Blanco
FSF. J. de Serres
F. J. de Serres
EFE. Fernandez-Bustillo
E. Fernandez-Bustillo
BLB. Lara
B. Lara
MMMarc Miravitlles
Marc Miravitlles
The current study focuses on developing estimates of the numbers of individuals carrying the two most common deficiency alleles, PI*S and PI*Z, for α1-antitrypsin deficiency (AT-D) in Europe.Criteria for selection of epidemiological studies were: 1) AT phenotyping performed by isoelectrofocusing or antigen–antibody crossed electrophoresis; 2) rejection of “screening studies”; 3) statistical precision factor score of ≥5 for Southwest, Western and Northern Europe, ≥4 for Central Europe, ≥3 for Eastern Europe; and 4) samples representative of the general population.A total of 75,390 individuals were selected from 21 European countries (one each from Austria, Belgium, Latvia, Hungary, Serbia-Montenegro, Sweden and Switzerland; two each from Denmark, Estonia and Lithuania; three each from Portugal and the UK; four each from Finland, the Netherlands, Norway and Spain; five each from Russia and Germany; six from Poland; eight from Italy; and nine from France). The total AT-D populations of a particular phenotype in the countries selected were: 124,594 ZZ; 560,515 SZ; 16,323,226 MZ; 630,401 SS; and 36,716,819 MS. The largest number of ZZ (5,000–15,000) were in Italy, Spain, Germany, France, the UK, Latvia, Sweden and Denmark, followed by Belgium, Portugal, Serbia-Montenegro, Russia, The Netherlands, Norway and Austria (1,000–2,000), with <1,000 in each of the remaining countries.A remarkable lack in number of reliable epidemiological studies and marked differences among these European countries and regions within a given country was also found.

29 August 2012 in Therapeutic Advances in Respiratory Disease
Verified
Journal Article
Closed access
PDF file
FSFrederick J. de Serres
Frederick J. de Serres
IBIgnacio Blanco
Ignacio Blanco
Genetic epidemiological studies on the prevalence and numbers of individuals with α1-antitrypsin deficiency in each of 97 countries worldwide were used to estimate the numbers in each of the five following phenotypic classes: PI*MS, PI*MZ, PI*SS, PI*SZ, and PI*ZZ. These 97 countries were then grouped into 10 major geographic regions to make it possible to compare the numbers in each of these five phenotypic classes in immediately adjacent countries. Such groupings also make it possible to review the spread of the PI*S and PI*Z alleles from one major geographic grouping to another in the world as well as the spread of these two deficiency alleles within a major geographic region. The data in the 10 tables on the numbers in each of the five phenotypic classes in the countries in the same geographic region as well as the prevalence of the PI*S and PI*Z alleles in countries in the same geographic region provide a novel database for the identification of large numbers of individuals in a given phenotypic class. The database also provides useful information for the identification of countries with high numbers of PI*ZZ individuals for augmentation therapy within a given geographic region.

1 February 2017 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
IBIgnacio Blanco
Ignacio Blanco
PBPatricia Bueno
Patricia Bueno
IAIsidro Alvarez
Isidro Alvarez
SPSergio Pérez-Holanda
Sergio Pérez-Holanda
FCFrancisco Casas-Maldonado
Francisco Casas-Maldonado
MMMarc Miravitlles
Marc Miravitlles
In alpha-1 antitrypsin deficiency (AATD), the Z allele is present in 98% of cases with severe disease, and knowledge of the frequency of this allele is essential from a public health perspective. However, there is a remarkable lack of epidemiological data on AATD worldwide, and many of the data currently used are outdated. Therefore, the objective of this study was to update the knowledge of the frequency of the Z allele to achieve accurate estimates of the prevalence and number of Pi*ZZ genotypes worldwide based on studies performed according to the following criteria: 1) samples representative of the general population, 2) AAT phenotyping characterized by adequate methods, and 3) measurements performed using a coefficient of variation calculated from the sample size and 95% confidence intervals. Studies fulfilling these criteria were used to develop maps with an inverse distance weighted (IDW)-interpolation method, providing numerical and graphical information of Pi*Z distribution worldwide. A total of 224 cohorts from 65 countries were included in the study. With the data provided by these cohorts, a total of 253,404 Pi*ZZ were estimated worldwide: 119,594 in Europe, 91,490 in America and Caribbean, 3,824 in Africa, 32,154 in Asia, 4,126 in Australia, and 2,216 in New Zealand. In addition, the IDW-interpolation maps predicted Pi*Z frequencies throughout the world even in some areas that lack real data. In conclusion, the inclusion of new well-designed studies and the exclusion of the low-quality ones have significantly improved the reliability of results, which may be useful to plan strategies for future research and diagnosis and to rationalize the therapeutic resources available.

18 April 2019 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
IBIgnacio Blanco
Ignacio Blanco
IAIsidro Alvarez
Isidro Alvarez
PBPatricia Bueno
Patricia Bueno
FCFrancisco Casas-Maldonado
Francisco Casas-Maldonado
MMMarc Miravitlles
Marc Miravitlles

30 April 2010 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
IBIgnacio Blanco
Ignacio Blanco
NVNana Beridze Vaktangova
Nana Beridze Vaktangova
MAMario Argüelles
Mario Argüelles
VCVictoriano Cárcaba
Victoriano Cárcaba
FFFernando Fernández
Fernando Fernández
MHMorley D. Hollenberg
Morley D. Hollenberg